Evidence map›Paper›PMID 40662843›Full record

ArticleBioinformatics (Oxford, England)2025

Trustworthy causal biomarker discovery: a multiomics brain imaging genetics-based approach.

Jin Zhang, Yan Yang, Muheng Shang, Lei Guo, Daoqiang Zhang, Lei Du, and the Alzheimer’s Disease Neuroimaging Initiative

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jin ZhangDepartment of Intelligent Science and Technology, Northwestern Polytechnical University School of Automation, Shaanxi 710072, China.
Yan YangDepartment of Intelligent Science and Technology, Northwestern Polytechnical University School of Automation, Shaanxi 710072, China.
Muheng ShangDepartment of Intelligent Science and Technology, Northwestern Polytechnical University School of Automation, Shaanxi 710072, China.
Lei GuoDepartment of Intelligent Science and Technology, Northwestern Polytechnical University School of Automation, Shaanxi 710072, China.
Daoqiang ZhangSchool of Artificial Intelligence, Nanjing University of Aeronautics and Astronautics, Nanjing 210000, China.
Lei DuDepartment of Intelligent Science and Technology, Northwestern Polytechnical University School of Automation, Shaanxi 710072, China.ORCID 0000-0002-6698-9814
and the Alzheimer’s Disease Neuroimaging Initiative

Funding

Fundamental Research Funds for the Central Universities at Northwestern Polytechnical UniversityInnovation Foundation for Doctor Dissertation CX2023062National Natural Science Foundation of China 62136004National Natural Science Foundation of China 62373306STI2030-Major Projects 2022ZD0213700
6 · The paper itself

Abstract

motivationDiscovering genetic variations underpinning brain disorders is important to understand their pathogenesis. Indirect associations or spurious causal relationships pose a threat to the reliability of biomarker discovery for brain disorders, potentially misleading or incurring bias in subsequent decision-making. Unfortunately, the stringent selection of reliable biomarker candidates for brain disorders remains a predominantly unexplored challenge.

resultsIn this article, to fill this gap, we propose a fresh and powerful scheme, referred to as the Causality-aware Genotype intermediate Phenotype Correlation Approach (Ca-GPCA). Specifically, we design a bidirectional association learning framework, integrated with a parallel causal variable decorrelation module and sparse variable regularizer module, to identify trustworthy causal biomarkers. A disease diagnosis module is further incorporated to ensure accurate diagnosis and identification of causal effects for pathogenesis. Additionally, considering the large computational burden incurred by high-dimensional genotype-phenotype covariances, we develop a fast and efficient strategy to reduce the runtime and prompt practical availability and applicability. Extensive experimental results on four simulation data and real neuroimaging genetic data clearly show that Ca-GPCA outperforms state-of-the-art methods with excellent built-in interpretability. This can provide novel and reliable insights into the underlying pathogenic mechanisms of brain disorders. AVAILABILITY AND IMPLEMENTATION: The software is publicly available at https://github.com/ZJ-Techie/Ca-GPCA.

Indexed as

BrainBrain DiseasesNeuroimagingAlgorithmsBiomarkersGenomicsGenotypeHumansMultiomicsPhenotypeBiomarkers

Identifiers

PMID40662843
PMCPMC12261482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.